Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

British Journal of Cancer

Volumn 94, Issue 4, 2006, Pages 524-531

  Furstenberger G ^a   Von Moos, R ^b   Lucas, R ^c   Thurlimann B ^b   Senn, H J ^a   Hamacher, J ^d   Boneberg, E M ^e  

^a Tumor Center ZeTuP   (Switzerland)

^b Kantonsspital St Gallen   (Switzerland)

^c UNIVERSITY OF KONSTANZ   (Germany)

^d SAARLAND UNIVERSITY   (Germany)

^e UNIVERSITY OF KONSTANZ   (Switzerland)

Author keywords

Angiogenesis; Angiogenic factors; Breast cancer; Chemotherapy; Circulating endothelial cells

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 2; ANTHRACYCLINE; CYCLOPHOSPHAMIDE; DOCETAXEL; ENDOGLIN; ENDOSTATIN; EPIRUBICIN; ERYTHROPOIETIN; FLUOROURACIL; TAXANE DERIVATIVE; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER SURGERY; CD34 SELECTION; CELL COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; PRIORITY JOURNAL; STEM CELL;

ADULT; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL MOVEMENT; DISEASE PROGRESSION; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GROWTH SUBSTANCES; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 33344459620     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602952     Document Type: Article

References (31)

1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM (1999b) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967
3. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM (1999a) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972
4. Bahlmann FH, De Groot K, Spandau JM, Landry AL, Hertel B, Duckert T, Boehm SM, Menne J, Haller H, Fliser D (2004) Erythropoietin regulates endothelial progenitor cells. Blood 103: 921-926
5. Beerepoot LV, Mehra N, Vermaat JS, Zonnenberg BA, Gebbink MF, Voest EE (2004) Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol 15: 139-145
6. Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R, Taraboletti G (1996) The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 2: 843-849
7. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3: 401-410
8. Cavailles V, Augereau P, Rochefort H (1993) Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci USA 90: 203-207
9. Davidoff AM, Ng CY, Brown P, Leary MA, Spurbeck WW, Zhou J, Horwitz E, Vanin EF, Nienhuis AW (2001) Bone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in mice. Clin Cancer Res 7: 870-879
10. Felbor U, Dreier L, Bryant RA, Ploegh HL, Olsen BR, Mothes W (2000) Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J 19: 1187-1194
11. Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaisse J (2000) Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 486: 247-251
12. George F, Brouqui P, Boffa MC, Mutin M, Drancourt M, Brisson C, Raoult D, Sampol J (1993) Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever. Blood 82: 2109-2116
13. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM (2002) AJCC Cancer Staging Handbook. New York: Springer
14. Hotchkiss KA, Ashton AW, Mahmood R, Russell RG, Sparano JA, Schwartz EL (2002) Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center. Mol Cancer Ther 1: 1191-2000
15. Hristov M, Erl W, Weber PC (2003) Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23: 1185-1189
16. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, Asahara T (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97: 3422-3427
17. Lennernas B, Albertsson P, Lennernas H, Norrby K (2003) Chemotherapy and antiangiogenesis-drug-specific, dose-related effects. Acta Oncol 42: 294-303
18. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77
19. Mancuso P, Burlini A, Pruneri G, Goldhirsch A, Martinelli G, Bertolini F (2001) Resting and activated endothelial cells are increased in the peripheral blood of cancer patients. Blood 97: 3658-3661
20. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, Imaizumi T (2000) Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105: 1527-1536
21. Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F (1999) Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 93: 2951-2958
22. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958
23. Rafii S (2000) Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 105: 17-19
24. Rafii S, Heissig B, Hattori K (2002a) Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors. Gene Therapy 9: 631-641
25. Rafii S, Lyden D, Benezra R, Hattori K, Heissig B (2002b) Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2: 826-835
26. Ribatti D (2004) The involvement of endothelial progenitor cells in tumor angiogenesis. J Cell Mol Med 8: 294-300
27. Schwartzberg LS, Birch R, Hazelton B, Tauer KW, Lee P, Altemose MD, George C, Blanco R, Wittlin F, Cohen J, Muscato J, West WH (1992) Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor. J Hematother 1: 317-327
28. Sinn HP, Schmid H, Junkermann H, Huober J, Leppien G, Kaufmann M, Bastert G, Otto HF (1994) Histologic regression of breast cancer after primary (neoadjuvant) chemotherapy. Geburtshilfe Frauenheilkd 54: 552-558
29. Skovseth DK, Veuger MJ, Sorensen DR, De Angelis PM, Haraldsen G (2005) Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis and perivascular cell recruitment in vivo. Blood 105: 1044-1051
30. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438
31. Zhao J, Yan F, Ju H, Tang J, Qin J (2004) Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer. Cancer Lett 204: 87-95